 Fortress Biotech NASDAQ:FBIO was downgraded by analysts at BidaskClub from a buy rating to a hold rating in a research report issued on Wednesday, BidAskClub reports. FBIO has been the topic of a number of other research reports. ValuEngine raised shares of Fortress Biotech from a hold rating to a buy rating in a report ... 